Jakarta - Delayed Quote IDR

PT Metro Healthcare Indonesia Tbk (CARE.JK)

Compare
186.00 -5.00 (-2.62%)
At close: December 27 at 4:12:33 PM GMT+7
Loading Chart for CARE.JK
DELL
  • Previous Close 191.00
  • Open 191.00
  • Bid 186.00 x --
  • Ask 187.00 x --
  • Day's Range 186.00 - 196.00
  • 52 Week Range 56.00 - 196.00
  • Volume 65,547,700
  • Avg. Volume 43,460,293
  • Market Cap (intraday) 6.185T
  • Beta (5Y Monthly) -0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -2.70
  • Earnings Date Oct 31, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It is involved in the management of clinics, treatment halls, polyclinics, and other medical centers; healthcare, physical medicine, and trading businesses; operates private polyclinics; and provides industry, development, and services, as well as health and management consulting services. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Metro Healthcare International.

www.metrohealthcareindonesia.co.id

802

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CARE.JK

View More

Performance Overview: CARE.JK

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CARE.JK
16.25%
IDX COMPOSITE
3.25%

1-Year Return

CARE.JK
20.00%
IDX COMPOSITE
2.78%

3-Year Return

CARE.JK
62.65%
IDX COMPOSITE
7.22%

5-Year Return

CARE.JK
43.08%
IDX COMPOSITE
11.35%

Compare To: CARE.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CARE.JK

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    6.18T

  • Enterprise Value

    6.59T

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    20.03

  • Price/Book (mrq)

    2.04

  • Enterprise Value/Revenue

    21.36

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.95%

  • Return on Assets (ttm)

    -0.43%

  • Return on Equity (ttm)

    -2.90%

  • Revenue (ttm)

    308.72B

  • Net Income Avi to Common (ttm)

    -89.39B

  • Diluted EPS (ttm)

    -2.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    513.13B

  • Total Debt/Equity (mrq)

    30.49%

  • Levered Free Cash Flow (ttm)

    -101.43B

Research Analysis: CARE.JK

View More

People Also Watch